Novel mutations in hyper‐IgM syndrome type 2 and X‐linked agammaglobulinemia detected in three patients with primary immunodeficiency disease-Reference-Cited by-同舟云学术

Novel mutations in hyper‐IgM syndrome type 2 and X‐linked agammaglobulinemia detected in three patients with primary immunodeficiency disease

Published:2020-12-30 Issue:1 Volume:9 Page:
ISSN:2324-9269
Container-title:Molecular Genetics & Genomic Medicine
language:en
Short-container-title:Mol Genet Genomic Med

Author:

Chen Xihui¹^ORCID,Liu Fangfang²,Yuan Lijuan¹³,Zhang Meng¹,Chen Kun⁴,Wu Yuanming¹

Affiliation:

1. Department of Biochemistry and Molecular Biology The Fourth Military Medical University Xi’an China

2. Institute of Neurosciences The Fourth Military Medical University Xi'an, Shaanxi China

3. Department of General Surgery Tangdu HospitalThe Fourth Military Medical University Xi’an China

4. Department of Anatomy, Histology and Embryology and K.K. Leung Brain Research Centre The Fourth Military Medical University Xi'an China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Genetics (clinical),Genetics,Molecular Biology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mgg3.1552

Reference29 articles.

1. X-Linked Agammagobulinemia in a Large Series of North African Patients: Frequency, Clinical Features and Novel BTK Mutations

2. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency;Al‐Herz W.;Frontiers in Immunology,2014

3. Primary immunodeficiency diseases. Report of a WHO scientific group;Anon;Clinical and Experimental Immunology,1997

4. Bruton's Tyrosine Kinase Links the B Cell Receptor to Nuclear Factor κb Activation

5. Clinical characteristics and genetic profiles of 174 patients with X-linked agammaglobulinemia

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of four novel mutations in BTK from six Chinese families with X-linked agammaglobulinemia;Clinica Chimica Acta;2022-06

2. Efficacy of ruxolitinib in B‐lymphoblastic leukaemia with the PCM1 – JAK2 fusion gene;British Journal of Haematology;2021-01-27